Jubilant Pharmova Share Price (JUBLPHARMA)
as on 01 Aug 2025, 04:01 PM IST
| Source : NSE
Jubilant Pharmova Stock Performance
as on 01 Aug 2025, 04:01 PM IST
Day's Low
Day's High
₹1,150.5₹1,194.3
0.68%
Downside
3.10%
Upside
52 Week's Low
52 Week's High
₹721.75₹1,309.937.69%
Downside
13.08%
Upside
| Market Stats | |
| Previous Close | ₹1,194.10 |
| Open | ₹1,180.00 |
| Volume | 3.06L |
| Upper Circuit | ₹1,432.90 |
| Lower Circuit | ₹955.30 |
| Day's Low | ₹1,150.5 |
| Day's High | ₹1,194.3 |
| 52 Week Low | ₹721.75 |
| 52 Week High | ₹1,309.9 |
| Returns % | |
| 1 Month Return | -3.29 % |
| 3 Month Return | + 27.72 % |
| 1 Year Return | + 36.06 % |
| 3 Year Return | + 220.89 % |
| 5 Year Return | + 55.01 % |
Jubilant Pharmova Stock Fundamentals & Key Indicators
Check Jubilant Pharmova market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹18,453.31 Cr
Return on Equity (ROE)
1.32
PE Ratio (TTM)
39.89
Return on capital employed (ROCE)
2.57
Industry PE ratio
44.86
Beta (LTM)
0.81
P/B Ratio
3.81
Dividend Yield
0.88
PEG Ratio
-6.8
Quarterly Earnings Growth YOY
-78.73
EPS (TTM)
4.6
Sector
Pharmaceuticals
Book Value
343.92
Technical Analysis
Bearish
View Technical Analysis
Jubilant Pharmova Stock's Interest Amongst Investors
Jubilant Pharmova Stock Valuation
Track how Jubilant Pharmova P/E has moved over time to understand its valuation trends.
Jubilant Pharmova in the last 5 years
Lowest (-195.50x)
December 29, 2023
Today (39.89x)
August 1, 2025
Industry (44.86x)
August 1, 2025
Highest (257.22x)
February 16, 2024
Today’s Price to Earnings Ratio: 39.89x
Jubilant Pharmova Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Jubilant Pharmova.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Jubilant Pharmova. Average target price of ₹1299.5
Source: S&P Global Market Intelligence
Jubilant Pharmova Share Price Target
Get share price movements and forecasts by analysts on Jubilant Pharmova.
Jubilant Pharmova price forecast by 2 analysts
Upside of12.18%
High
₹1385
Target
₹1299.50
Low
₹1214
Jubilant Pharmova target price ₹1299.5, a slight upside of 12.18% compared to current price of ₹1158.4. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Jubilant Pharmova revenue growth forecast
Expected growth rate Q1, FY2027:40.70%
Forecast
Actual
Including amortisation and stock based compensations
Jubilant Pharmova EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Jubilant Pharmova Ltd Financial Results
Get the annual and quarterly financial summary of Jubilant Pharmova Ltd, including revenue, profit, loss and more.
Jubilant Pharmova Earnings and Dividends
View detailed summary of the earnings and dividend history of Jubilant Pharmova.
Jubilant Pharmova Ltd Earnings Results
Jubilant Pharmova Ltd’s net profit fell -78.66% since last year same period to ₹102.90Cr in the Q1 2025-2026. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -33.01% fall in its net profits since last 3-months.
Read More about Earnings ResultsJubilant Pharmova Ltd Dividends May,2025
In the quarter ending March 2025, Jubilant Pharmova Ltd has declared dividend of ₹5.00 per share on 16 May 2025 - translating a dividend yield of 0.86%.
Read More about Dividends
Indices Featuring Jubilant Pharmova Stock
Check stock indices that include Jubilant Pharmova.
Jubilant Pharmova Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Jubilant Pharmova.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 47.68% | ||
| Foreign Institutions | 17.4% | 1.05 | |
| Mutual Funds | 6.01% | 64.25 | |
| Retail Investors | 24.84% | 1.38 | |
| Others | 4.07% | 3.29 |
Jubilant Pharmova Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Jubilant Pharmova with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 18,453.31 | 11% | 0.57 | 72 | 6,702 | |
| BUY | 37,466.71 | 39.28% | 0.52 | 300 | 1,051 | |
| NA | 4,862.63 | -3.21% | 1.95 | -343 | 71 | |
| BUY | 15,502.88 | 47.82% | 0.67 | 244 | 1,515 | |
| HOLD | 19,744.33 | 74.47% | 0.55 | 258 | 1,375 |
Jubilant Pharmova News & Key Events
Latest news and events in one place to help you make informed investing decisions in Jubilant Pharmova.
Jubilant Pharmova Faces USFDA Observations Post Inspection - 02 Aug, 2025
Jubilant Pharmova's Roorkee facility received four observations from the USFDA following a Pre-Approval Inspection. The facility's US revenue contribution is less than 1% of total revenue.Jubilant Pharmova Faces Profit Decline and Stock Drop - 29 Jul, 2025
Jubilant Pharmova reported a significant 78.66% decline in Q1 profit, despite a 9.76% revenue increase. The stock fell 4.2% amid these results and the CFO's resignation.MarketSmith India's Top Stock Picks for Jubilant Pharmova - 21 Jul, 2025
MarketSmith India recommends Jubilant Pharmova Ltd, citing strong financial growth and a cup with handle pattern breakout. Buy at ₹ 1,232 with a target of ₹ 1,390 in 2-3 months.Jubilant Pharmova Complies with SEBI Regulations - 04 Jul, 2025
Jubilant Pharmova Limited has submitted a confirmation certificate to stock exchanges, ensuring compliance with SEBI regulations for Q2 2025, reinforcing transparency and proper record-keeping.
Insights on Jubilant Pharmova Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, JUBLPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 24.50% to 24.84% in Jun 2025 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, JUBLPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 17.22% to 17.40% in Jun 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, JUBLPHARMA stock has moved up by 27.7%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 3.66% to 6.01% in Jun 2025 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 1.94K Cr → 1.91K Cr (in ₹), with an average decrease of 1.4% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 50.68% to 47.68% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 153.6 Cr → 102.9 Cr (in ₹), with an average decrease of 33.0% per quarter
About Jubilant Pharmova Ltd
Revenue: ₹1,878.90Cr as on June 2025 (Q1 FY26)
Net Profit: ₹102.50Cr as on June 2025 (Q1 FY26)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Pharmova Ltd |
| Headquarters | Noida |
| Industry | Pharmaceuticals |
| CEO | Shyam S Bhartia |
| E-voting on shares | Click here to vote |
Mutual Funds that own Jubilant Pharmova Stock
Check out the Mutual Funds with significant holdings in Jubilant Pharmova.
FAQs
What is Jubilant Pharmova share price today?
Jubilant Pharmova share price today stands at ₹1158.4, Open: ₹1180, Previous Close: ₹1194.1, High: ₹1194.3, Low: ₹1150.5, 52 Week High: ₹1309.9, 52 Week Low: ₹721.75 as on 01 Aug 2025, 04:01 PM IST.
How to buy Jubilant Pharmova shares ?
To buy Jubilant Pharmova shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for JUBLPHARMA or Jubilant Pharmova Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Jubilant Pharmova shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Jubilant Pharmova?
Today's traded volume of Jubilant Pharmova is 3.06L. Which means that 3.06L shares of Jubilant Pharmova were bought and sold on the stock market during today's trading session.
What is Jubilant Pharmova's market cap today?
Today's market capitalisation of Jubilant Pharmova is ₹18,453.31 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Jubilant Pharmova?
Jubilant Pharmova’s 52 week high is ₹1309.9 and 52 week low is ₹721.75. The current share price of Jubilant Pharmova is ₹1158.4, which is -11.57% down from its 52 week high and 60.50% up from its 52 week low.